292 related articles for article (PubMed ID: 21474366)
1. MicroRNAs: new actors in the oral cancer scene.
Wu BH; Xiong XP; Jia J; Zhang WF
Oral Oncol; 2011 May; 47(5):314-9. PubMed ID: 21474366
[TBL] [Abstract][Full Text] [Related]
2. MicroRNAs in an oral cancer context - from basic biology to clinical utility.
Gorenchtein M; Poh CF; Saini R; Garnis C
J Dent Res; 2012 May; 91(5):440-6. PubMed ID: 22166582
[TBL] [Abstract][Full Text] [Related]
3. microRNA expression profiles in oral squamous cell carcinoma.
Soga D; Yoshiba S; Shiogama S; Miyazaki H; Kondo S; Shintani S
Oncol Rep; 2013 Aug; 30(2):579-83. PubMed ID: 23708842
[TBL] [Abstract][Full Text] [Related]
4. Current trends in miRNAs and their relationship with oral squamous cell carcinoma.
Pérez-Sayáns M; Pilar GD; Barros-Angueira F; Suárez-Peñaranda JM; Fernández AC; Gándara-Rey JM; García-García A
J Oral Pathol Med; 2012 Jul; 41(6):433-43. PubMed ID: 22188431
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
Su L; Wang Y; Xiao M; Lin Y; Yu L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
[TBL] [Abstract][Full Text] [Related]
6. miR-24 up-regulation in oral carcinoma: positive association from clinical and in vitro analysis.
Lin SC; Liu CJ; Lin JA; Chiang WF; Hung PS; Chang KW
Oral Oncol; 2010 Mar; 46(3):204-8. PubMed ID: 20138800
[TBL] [Abstract][Full Text] [Related]
7. Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer.
Kozaki K; Imoto I; Mogi S; Omura K; Inazawa J
Cancer Res; 2008 Apr; 68(7):2094-105. PubMed ID: 18381414
[TBL] [Abstract][Full Text] [Related]
8. Passenger strand miRNA miR-31* regulates the phenotypes of oral cancer cells by targeting RhoA.
Chang KW; Kao SY; Wu YH; Tsai MM; Tu HF; Liu CJ; Lui MT; Lin SC
Oral Oncol; 2013 Jan; 49(1):27-33. PubMed ID: 22854067
[TBL] [Abstract][Full Text] [Related]
9. Evaluating the role of microRNAs alterations in oral squamous cell carcinoma.
Aali M; Mesgarzadeh AH; Najjary S; Abdolahi HM; Kojabad AB; Baradaran B
Gene; 2020 Oct; 757():144936. PubMed ID: 32640301
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-155 in oral squamous cell carcinoma: Overexpression, localization, and prognostic potential.
Shi LJ; Zhang CY; Zhou ZT; Ma JY; Liu Y; Bao ZX; Jiang WW
Head Neck; 2015 Jul; 37(7):970-6. PubMed ID: 24692283
[TBL] [Abstract][Full Text] [Related]
11. miR-181a shows tumor suppressive effect against oral squamous cell carcinoma cells by downregulating K-ras.
Shin KH; Bae SD; Hong HS; Kim RH; Kang MK; Park NH
Biochem Biophys Res Commun; 2011 Jan; 404(4):896-902. PubMed ID: 21167132
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs: Modulators of the Ras Oncogenes in Oral Cancer.
Murugan AK; Munirajan AK; Alzahrani AS
J Cell Physiol; 2016 Jul; 231(7):1424-31. PubMed ID: 26620726
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA and oral cancer: future perspectives.
Gomes CC; Gomez RS
Oral Oncol; 2008 Oct; 44(10):910-4. PubMed ID: 18620891
[TBL] [Abstract][Full Text] [Related]
14. miR‑543 acts as a novel oncogene in oral squamous cell carcinoma by targeting CYP3A5.
Wang L; Chen W; Zha J; Yan Y; Wei Y; Chen X; Zhu X; Ge L
Oncol Rep; 2019 Sep; 42(3):973-990. PubMed ID: 31322243
[TBL] [Abstract][Full Text] [Related]
15. MicroRNAs: small molecules with a potentially role in oral squamous cell carcinoma.
Gomes CC; de Sousa SF; Gomez RS
Curr Pharm Des; 2013; 19(7):1285-91. PubMed ID: 23092348
[TBL] [Abstract][Full Text] [Related]
16. Potential of tumor-suppressive miR-596 targeting LGALS3BP as a therapeutic agent in oral cancer.
Endo H; Muramatsu T; Furuta M; Uzawa N; Pimkhaokham A; Amagasa T; Inazawa J; Kozaki K
Carcinogenesis; 2013 Mar; 34(3):560-9. PubMed ID: 23233740
[TBL] [Abstract][Full Text] [Related]
17. MicroRNAs contribute to the chemoresistance of cisplatin in tongue squamous cell carcinoma lines.
Yu ZW; Zhong LP; Ji T; Zhang P; Chen WT; Zhang CP
Oral Oncol; 2010 Apr; 46(4):317-22. PubMed ID: 20219416
[TBL] [Abstract][Full Text] [Related]
18. Endothelins and their receptors as biological markers for oral cancer.
Hoffmann RR; Yurgel LS; Campos MM
Oral Oncol; 2010 Sep; 46(9):644-7. PubMed ID: 20656542
[TBL] [Abstract][Full Text] [Related]
19. CircDOCK1 suppresses cell apoptosis via inhibition of miR‑196a‑5p by targeting BIRC3 in OSCC.
Wang L; Wei Y; Yan Y; Wang H; Yang J; Zheng Z; Zha J; Bo P; Tang Y; Guo X; Chen W; Zhu X; Ge L
Oncol Rep; 2018 Mar; 39(3):951-966. PubMed ID: 29286141
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of microRNA 99a in oral squamous cell carcinomas contributes to the growth and survival of oral cancer cells.
Yan B; Fu Q; Lai L; Tao X; Fei Y; Shen J; Chen Z; Wang Q
Mol Med Rep; 2012 Sep; 6(3):675-81. PubMed ID: 22751686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
